Corien Eeltink

Paclitaxel (TAXOL®) concentrations in brain tumor tissue

J.J. Heimans, J. B. Vermorken, J.G. Wolbers et al. · Annals of Oncology · 1994 · 133 citations

Medicine, Pharmacokinetics, Pharmacology +12

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment

Theresia M. Westers, Canan Alhan, Martine E.D. Chamuleau et al. · Blood · 2009 · 92 citations

Medicine, Hematology, Oncology +12

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

Arjan A. van de Loosdrecht, Sandra van Wetering, Saskia J. Santegoets et al. · Cancer Immunology Immunotherapy · 2018 · 88 citations · Full text

Life Sciences, Immunology, Oncology +13

A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors.

Giuseppe Giaccone, Sabine C. Linn, Jan Welink et al. · PubMed · 1997 · 85 citations · Full text

Medicine, Oncology, Pharmacology +13

Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation

Linda Bouwman, Corien Eeltink, Otto Visser et al. · BMC Cancer · 2017 · 76 citations · Full text

Medicine, Oncology, Hematologic Oncology +11